BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perera AP, Sajnani K, Dickinson J, Eri R, Körner H. NLRP3 inflammasome in colitis and colitis-associated colorectal cancer. Mamm Genome 2018;29:817-30. [DOI: 10.1007/s00335-018-9783-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Tezcan G, Garanina EE, Zhuravleva MN, Hamza S, Rizvanov AA, Khaiboullina SF. Rab GTPase Mediating Regulation of NALP3 in Colorectal Cancer. Molecules 2020;25:E4834. [PMID: 33092247 DOI: 10.3390/molecules25204834] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Huang H, Wang X, Zhang X, Zhang G, Jinbo M, Wang H, Yu P, Jiang W. Ganciclovir reduces irinotecan-induced intestinal toxicity by inhibiting NLRP3 activation. Cancer Chemother Pharmacol 2020;85:195-204. [DOI: 10.1007/s00280-019-03996-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Salama RH, Sayed ZEA, Ashmawy AM, Elsewify WA, Ezzat GM, Mahmoud MA, Alsanory AA, Alsanory TA. Interrelations of Apoptotic and Cellular Senescence Genes Methylation in Inflammatory Bowel Disease Subtypes and Colorectal Carcinoma in Egyptians Patients. Appl Biochem Biotechnol 2019;189:330-43. [PMID: 30989570 DOI: 10.1007/s12010-019-03017-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Anderson S, Grist JT, Lewis A, Tyler DJ. Hyperpolarized 13 C magnetic resonance imaging for noninvasive assessment of tissue inflammation. NMR Biomed 2021;34:e4460. [PMID: 33291188 DOI: 10.1002/nbm.4460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Han YM, A Kang E, Min Park J, Young Oh J, Yoon Lee D, Hye Choi S, Baik Hahm K. Dietary intake of fermented kimchi prevented colitis-associated cancer. J Clin Biochem Nutr 2020;67:263-73. [PMID: 33293767 DOI: 10.3164/jcbn.20-77] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lin TY, Tsai MC, Tu W, Yeh HC, Wang SC, Huang SP, Li CY. Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks. Front Immunol 2020;11:610492. [PMID: 33613533 DOI: 10.3389/fimmu.2020.610492] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Behren A, Speidel D, Kollias G, Howell VM. Introduction to Mammalian Genome special issue: inflammation and immunity in cancer. Mamm Genome 2018;29:691-3. [PMID: 30390107 DOI: 10.1007/s00335-018-9787-y] [Reference Citation Analysis]
8 Missiroli S, Perrone M, Boncompagni C, Borghi C, Campagnaro A, Marchetti F, Anania G, Greco P, Fiorica F, Pinton P, Giorgi C. Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer. Cancers (Basel) 2021;13:2297. [PMID: 34064909 DOI: 10.3390/cancers13102297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ghanawat M, Arjmand B, Rahim F. The Pro-tumor and Anti-tumor Effects of NLRP3 Inflammasome as a New Therapeutic Option for Colon Cancer: a Meta-analysis of Pre-clinical Studies. J Gastrointest Cancer 2022. [PMID: 35072914 DOI: 10.1007/s12029-022-00805-3] [Reference Citation Analysis]
10 Choi HR, Lim H, Lee JH, Park H, Kim HP. Interruption of Helicobacter pylori-Induced NLRP3 Inflammasome Activation by Chalcone Derivatives. Biomol Ther (Seoul) 2021;29:410-8. [PMID: 33653970 DOI: 10.4062/biomolther.2020.192] [Reference Citation Analysis]
11 Li H, Che H, Xie J, Dong X, Song L, Xie W, Sun J. Supplementary selenium in the form of selenylation α-D-1,6-glucan ameliorates dextran sulfate sodium induced colitis in vivo. Int J Biol Macromol 2022;195:67-74. [PMID: 34896151 DOI: 10.1016/j.ijbiomac.2021.11.189] [Reference Citation Analysis]
12 Dai G, Jiang Z, Sun B, Liu C, Meng Q, Ding K, Jing W, Ju W. Caffeic Acid Phenethyl Ester Prevents Colitis-Associated Cancer by Inhibiting NLRP3 Inflammasome. Front Oncol 2020;10:721. [PMID: 32435622 DOI: 10.3389/fonc.2020.00721] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Vong CT, Tseng HHL, Yao P, Yu H, Wang S, Zhong Z, Wang Y. Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases. Drug Discov Today 2021;26:1394-408. [PMID: 33636340 DOI: 10.1016/j.drudis.2021.02.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Owona BA, Abia WA, Moundipa PF. Natural compounds flavonoids as modulators of inflammasomes in chronic diseases. Int Immunopharmacol 2020;84:106498. [PMID: 32304996 DOI: 10.1016/j.intimp.2020.106498] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
15 Ngui IQH, Perera AP, Eri R. Does NLRP3 Inflammasome and Aryl Hydrocarbon Receptor Play an Interlinked Role in Bowel Inflammation and Colitis-Associated Colorectal Cancer? Molecules 2020;25:E2427. [PMID: 32456012 DOI: 10.3390/molecules25102427] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Shao X, Lei Z, Zhou C. NLRP3 Promotes Colorectal Cancer Cell Proliferation and Metastasis via Regulating Epithelial Mesenchymal Transformation. Anticancer Agents Med Chem 2020;20:820-7. [PMID: 32077831 DOI: 10.2174/1871520620666200220112741] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Li H, Cao W, Xie J, Che H, Liu L, Dong X, Song L, Xie W. α-D-1,6-glucan from Castanea mollissima Blume alleviates dextran sulfate sodium-induced colitis in vivo. Carbohydrate Polymers 2022;289:119410. [DOI: 10.1016/j.carbpol.2022.119410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wang Y, Zhang H, Xu Y, Peng T, Meng X, Zou F. NLRP3 induces the autocrine secretion of IL-1β to promote epithelial-mesenchymal transition and metastasis in breast cancer. Biochem Biophys Res Commun 2021;560:72-9. [PMID: 33975248 DOI: 10.1016/j.bbrc.2021.04.122] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Pham DV, Park PH. Recent insights on modulation of inflammasomes by adipokines: a critical event for the pathogenesis of obesity and metabolism-associated diseases. Arch Pharm Res. 2020;43:997-1016. [PMID: 33078304 DOI: 10.1007/s12272-020-01274-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
20 Chen X, Zhou Y, Yu J. Exosome-like Nanoparticles from Ginger Rhizomes Inhibited NLRP3 Inflammasome Activation. Mol Pharm 2019;16:2690-9. [PMID: 31038962 DOI: 10.1021/acs.molpharmaceut.9b00246] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
21 Gouravani M, Khalili N, Razi S, Keshavarz-Fathi M, Khalili N, Rezaei N. The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers. Expert Rev Clin Immunol 2020;16:175-87. [PMID: 31928260 DOI: 10.1080/1744666X.2020.1713755] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
22 Shi F, Wei B, Lan T, Xiao Y, Quan X, Chen J, Zhao C, Gao J. Low NLRP3 expression predicts a better prognosis of colorectal cancer. Biosci Rep 2021;41:BSR20210280. [PMID: 33821998 DOI: 10.1042/BSR20210280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Abdullaha M, Mohammed S, Ali M, Kumar A, Vishwakarma RA, Bharate SB. Discovery of Quinazolin-4(3 H)-ones as NLRP3 Inflammasome Inhibitors: Computational Design, Metal-Free Synthesis, and in Vitro Biological Evaluation. J Org Chem 2019;84:5129-40. [PMID: 30896160 DOI: 10.1021/acs.joc.9b00138] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]